This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
and you are
over 18
years old
This is a second phase trial assessing
efficacy and side effects of the new treatment.
Show me locations

The purpose

The purpose of this study is to find out if bacterial load in the airways can be reduced after inhalation of ciprofloxacin for 28 days.

Provided treatments

  • Drug: Ciprofloxacin (Cipro, BAYQ3939)
  • Drug: Placebo
Tris trial is registered with FDA with number: NCT00930982. The sponsor of the trial is Bayer and it is looking for 124 volunteers for the current phase.
Official trial title:
Randomized, Placebo-controlled, Double-blind, Multi-center Study to Evaluate the Safety and Efficacy of Ciprofloxacin Inhale Compared to Placebo in Patients With Non-cystic Fibrosis Bronchiectasis